Related Experiment Video
Updated: Nov 16, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis
1Department of Neurology, People's Hospital of Zhenhai District, Ningbo, China. shangxs320@163.com.
Objective:
Renal cell carcinoma (RCC) is one of the most common urological malignancies worldwide. Although great advances have been made in the diagnosis and management of RCC, its prognosis remains unsatisfactory. Long noncoding RNAs (lncRNAs) have been found to be essential factors in the initiation and development of cancer. The current study aimed to measure the expression and functions of lncRNA DNAJC3-AS1 in the progression of clear cell RCC (ccRCC).
Patients And Methods:
The expression of lncRNA DNAJC3-AS1 was detected in 30 pairs of ccRCC tissues and in cell lines by RT-PCR, and its prognostic association with ccRCC was evaluated by the Kaplan-Meier method. The proliferation, migration, invasion and apoptosis of ccRCC cells were measured after silencing DNAJC3-AS1. The interaction between DNAJC3-AS1, miR-27a-3p and PRDM14 was identified by Dual-Luciferase reporter assay. The protein levels were measured by Western blotting.
Results:
The expression of DNAJC3-AS1 was upregulated in ccRCC tissues and cell lines compared to their normal counterparts. In vitro, silencing DNAJC3-AS1 reduced the proliferation, migration and invasion of ccRCC cells. Downregulation of DNAJC3-AS1 also led to the apoptosis of ccRCC cells. Moreover, we also found that DNAJC3-AS1 acted as a sponge of miR-27a-3p and identified PRDM14 as a target of miR-27a-3p.
Conclusions:
LncRNA DNAJC3-AS1 acts as an oncogene and plays an essential role in the tumorigenesis of ccRCC, possibly via the regulation of the miR-27a-3p/PRDM14 axis.
Insights
Long noncoding RNA DNAJC3-AS1 is upregulated in clear cell renal cell carcinoma (ccRCC). Silencing this lncRNA inhibits ccRCC progression by affecting cell proliferation, migration, invasion, and apoptosis via the miR-27a-3p/PRDM14 pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal cell carcinoma (RCC) is a prevalent urological malignancy with unsatisfactory prognosis despite diagnostic and therapeutic advancements.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their critical roles in cancer initiation and progression.
- Clear cell renal cell carcinoma (ccRCC) is the most common subtype of RCC, necessitating further understanding of its underlying molecular mechanisms.
Purpose of the Study:
- To investigate the expression and functional significance of lncRNA DNAJC3-AS1 in the tumorigenesis of ccRCC.
- To elucidate the molecular interactions involving DNAJC3-AS1, microRNA-27a-3p (miR-27a-3p), and PR domain containing 14 (PRDM14) in ccRCC.
Main Methods:
- Quantitative real-time PCR (RT-PCR) to assess DNAJC3-AS1 expression in ccRCC tissues and cell lines.
- In vitro experiments involving silencing DNAJC3-AS1 to evaluate its effects on ccRCC cell proliferation, migration, invasion, and apoptosis.
- Dual-luciferase reporter assays to confirm the interaction between DNAJC3-AS1, miR-27a-3p, and PRDM14.
- Western blotting to measure protein expression levels.
Main Results:
- DNAJC3-AS1 expression was significantly upregulated in ccRCC tissues and cell lines compared to normal controls.
- Silencing DNAJC3-AS1 inhibited ccRCC cell proliferation, migration, and invasion, while promoting apoptosis.
- DNAJC3-AS1 functions as a molecular sponge for miR-27a-3p, and PRDM14 was identified as a downstream target of miR-27a-3p.
Conclusions:
- LncRNA DNAJC3-AS1 acts as an oncogene in ccRCC development.
- The oncogenic role of DNAJC3-AS1 in ccRCC is mediated through the regulation of the miR-27a-3p/PRDM14 axis.
- Targeting the DNAJC3-AS1/miR-27a-3p/PRDM14 pathway may offer a novel therapeutic strategy for ccRCC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
